Literature DB >> 10474720

HIV infection and seizures.

R K Garg1.   

Abstract

New-onset seizures are frequent manifestations of central nervous system disorders in patients infected with human immunodeficiency virus (HIV). Seizures are more common in advanced stages of the disease, although they may occur early in the course of illness. In the majority of patients, seizures are of the generalised type. Status epilepticus is also frequent. Associated metabolic abnormalities increase the risk for status epilepticus. Cerebral mass lesions, cryptococcal meningitis, and HIV-encephalopathy are common causes of seizures. Phenytoin is the most commonly prescribed anticonvulsant in this situation, although several patients may experience hypersensitivity reactions. The prognosis of seizure disorders in HIV-infected patients depends upon the underlying cause.

Entities:  

Mesh:

Year:  1999        PMID: 10474720      PMCID: PMC1741302          DOI: 10.1136/pgmj.75.885.387

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  18 in total

1.  The spectrum of imaging and neuropsychological findings in Pick's disease.

Authors:  D S Knopman; K J Christensen; L J Schut; R E Harbaugh; T Reeder; T Ngo; W Frey
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

2.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

Review 3.  Nocardial brain abscess: treatment strategies and factors influencing outcome.

Authors:  A N Mamelak; W G Obana; J F Flaherty; M L Rosenblum
Journal:  Neurosurgery       Date:  1994-10       Impact factor: 4.654

4.  Neurologic sequelae associated with foscarnet therapy.

Authors:  E Lor; Y Q Liu
Journal:  Ann Pharmacother       Date:  1994-09       Impact factor: 3.154

5.  Seizures in human immunodeficiency virus infection.

Authors:  M C Wong; N D Suite; D R Labar
Journal:  Arch Neurol       Date:  1990-06

6.  Thalamomesencephalic strokes after cocaine abuse.

Authors:  H A Rowley; D H Lowenstein; M C Rowbotham; R P Simon
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

7.  Early seizures in patients with acquired immunodeficiency syndrome without mass lesions.

Authors:  G S Rosenbaum; N C Klein; B A Cunha
Journal:  Heart Lung       Date:  1989-09       Impact factor: 2.210

8.  New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases.

Authors:  D M Holtzman; D A Kaku; Y T So
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

Review 9.  AIDS-related dementia and calcium homeostasis.

Authors:  S A Lipton
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

10.  Metabolic abnormalities and new-onset seizures in human immunodeficiency virus-seropositive patients.

Authors:  W Van Paesschen; C Bodian; H Maker
Journal:  Epilepsia       Date:  1995-02       Impact factor: 5.864

View more
  12 in total

1.  Cognitive impairment and psychiatric morbidity in HIV+ Zambians with new-onset seizure.

Authors:  Lisa Kalungwana; Melissa A Elafros; Omar K Siddiqi; Christopher M Bositis; Izukanji Sikazwe; Igor J Koralnik; William H Theodore; Gretchen L Birbeck
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

2.  New-onset seizure in HIV-infected adult Zambians: A search for causes and consequences.

Authors:  Omar K Siddiqi; Melissa A Elafros; Christopher M Bositis; Igor J Koralnik; William H Theodore; Jason F Okulicz; Lisa Kalungwana; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck
Journal:  Neurology       Date:  2016-12-21       Impact factor: 9.910

3.  HIV and new onset seizures: slipping through the cracks in HIV care and treatment.

Authors:  I Sikazwe; M A Elafros; C M Bositis; O K Siddiqi; I J Koralnik; L Kalungwana; W H Theodore; J F Okulicz; M J Potchen; G L Birbeck
Journal:  HIV Med       Date:  2015-07-22       Impact factor: 3.180

Review 4.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

5.  Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era.

Authors:  Mathura Ravishankar; Ifunanya Dallah; Manoj Mathews; Christopher M Bositis; Musaku Mwenechanya; Lisa Kalungwana-Mambwe; David Bearden; Allison Navis; Melissa A Elafros; Harris Gelbard; William H Theodore; Igor J Koralnik; Jason F Okulicz; Brent A Johnson; Clara Belessiotis; Ornella Ciccone; Natalie Thornton; Melissa Tsuboyama; Omar K Siddiqi; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck
Journal:  Epilepsia Open       Date:  2022-04-01

Review 6.  Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition.

Authors:  Tolu Oni; Nigel Unwin
Journal:  Int Health       Date:  2015-06-23       Impact factor: 2.473

7.  Seizures in HIV: The case for special consideration.

Authors:  Lilia Zaporojan; Patricia H McNamara; Jennifer A Williams; Colm Bergin; Janice Redmond; Colin P Doherty
Journal:  Epilepsy Behav Case Rep       Date:  2018-03-13

Review 8.  Neurological disorders in HIV in Africa: a review.

Authors:  William P Howlett
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

9.  Alien hand syndrome in AIDS: Neuropsychological features and physiopathological considerations based on a case report.

Authors:  Leonardo Caixeta; Patrícia Maciel; Juliana Nunes; Larissa Nazareno; Letícia Araújo; Jules Rimet Borges
Journal:  Dement Neuropsychol       Date:  2007 Oct-Dec

Review 10.  Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review.

Authors:  Sonia Menon; Lenka Benova; Hillary Mabeya
Journal:  BMC Med       Date:  2020-11-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.